2018
DOI: 10.1111/epi.14004
|View full text |Cite
|
Sign up to set email alerts
|

Laser ablation is effective for temporal lobe epilepsy with and without mesial temporal sclerosis if hippocampal seizure onsets are localized by stereoelectroencephalography

Abstract: We report similar rates of seizure freedom following SLAH in patients with MTS and SEEG-confirmed, non-MTS MTLE. Consistent with early literature, these rates are slightly lower than typically observed with surgical resection (60%-80%). However, SLAH is less invasive than open surgery, with shorter hospital stays and recovery, and severe procedural complications are rare. SLAH may be a reasonable first-line surgical option for patients with both MTS and SEEG confirmed, non-MTS MTLE.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
65
2

Year Published

2018
2018
2022
2022

Publication Types

Select...
4
3

Relationship

2
5

Authors

Journals

citations
Cited by 75 publications
(73 citation statements)
references
References 33 publications
(100 reference statements)
6
65
2
Order By: Relevance
“…These outcomes are roughly comparable to traditional amygdalo‐hippocampectomies and anterior temporal lobe resections, and are better than previously published MRIgLITT case series . Compared to traditional anterior temporal resections, where Engel I surgical outcomes at 2 years of follow‐up is obtained for about 67% of patients, the Engel I surgical outcome obtained after MRIgLITT has been viewed as inferior by about 10%‐20% . Further, analyzing patients with a diagnosis of MTS and the necessity of SEEG investigations for seizure‐onset zone identification revealed no statistically significant differences between the percentages of patients with Engel class I surgical outcomes (Figure B).…”
Section: Discussionsupporting
confidence: 57%
See 1 more Smart Citation
“…These outcomes are roughly comparable to traditional amygdalo‐hippocampectomies and anterior temporal lobe resections, and are better than previously published MRIgLITT case series . Compared to traditional anterior temporal resections, where Engel I surgical outcomes at 2 years of follow‐up is obtained for about 67% of patients, the Engel I surgical outcome obtained after MRIgLITT has been viewed as inferior by about 10%‐20% . Further, analyzing patients with a diagnosis of MTS and the necessity of SEEG investigations for seizure‐onset zone identification revealed no statistically significant differences between the percentages of patients with Engel class I surgical outcomes (Figure B).…”
Section: Discussionsupporting
confidence: 57%
“…6,[8][9][10] Compared to traditional anterior temporal resections, where Engel I surgical outcomes at 2 years of follow-up is obtained for about 67% of patients, 43 the Engel I surgical outcome obtained after MRIgLITT has been viewed as inferior by about 10%-20%. 3,5,44,45 Further, analyzing patients with a diagnosis of MTS and the necessity of SEEG investigations for seizure-onset zone identification revealed no statistically significant differences between the percentages of patients with Engel class I surgical outcomes ( Figure 3B). This provides a first answer to Kang and Sperling's question 16 whether patients without evidence of mesial temporal sclerosis on MRI scans are good candidates for MRIgLITT.…”
Section: Seizure Outcomesmentioning
confidence: 93%
“…Single‐center case series report that LITT for MTLE is a safe and effective first‐line alternative to open temporal lobe surgery in cases of mesial temporal sclerosis or where mesial temporal seizure onset has been proven by SEEG . A recent meta‐analysis of LITT for MTLE has suggested an overall seizure freedom rate of 50% at 12‐36 months, rising to 62% when considering “lesional” cases only .…”
Section: Discussionmentioning
confidence: 99%
“…Single-center case series report that LITT for MTLE is a safe and effective first-line alternative to open temporal lobe surgery in cases of mesial temporal sclerosis or where mesial temporal seizure onset has been proven by SEEG. [3][4][5][6]12,24,25 A recent meta-analysis of LITT for MTLE has suggested an overall seizure freedom rate of 50% at 12-36 months, rising to 62% when considering "lesional" cases only. 26 Despite the promise of LITT as an alternative first-line therapy, a single case series has reported an overall complication rate of 22.4%, 27 including catheter misplacement, intracranial hemorrhage, device malfunction, hemiparesis, cranial neuropathy, and visual field deficits.…”
Section: Summary Of Litt Studies To Datementioning
confidence: 99%
See 1 more Smart Citation